Veeva Systems unveils new app MyVeeva for clinical research sites
Category: #health  By Pankaj Singh  Date: 2020-05-21
  • share
  • Twitter
  • Facebook
  • LinkedIn

Veeva Systems unveils new app MyVeeva for clinical research sites

Veeva Systems, a renowned leader in cloud-based software for the global life sciences industry, has reportedly unveiled a new application for clinical research sites. With competencies for patient adherence, eSource, eConsent, ePRO, virtual visits as well as an easy to use portal for patients.

The new application, MyVeeva, also makes it easy for the clinical research sites to bring a paperless clinical trial and patient-centric experience for sponsors and patients. The new application is free for clinical research sites and also integrates effortlessly with the Veeva SiteVault.

Jessica Collins, program director, investigator-initiated clinical trials, Vanderbilt University Medical Center, stated that there is a crucial need for clinical solutions that would decrease the load on patients taking part in clinical trials and would also make study implementation simpler for sites.

Collins further stated that having the capability to perform parts of a clinical study remotely is critical to a superior patient experience and a fast-moving study conduct.

The new application empowers clinical research coordinators, doctors, and patients to cooperate remotely through advanced audio & video abilities, thereby decreasing the need for face to face visits. Clinical researchers could collect as well as record the patient data by electronic means, this further makes it easy for patients to report on treatment results.

The researchers could share information electronically with ease and could also get the patient permission. It could also help the patients in taking medicines and stick to their treatment schedules as well.

Henry Levy, GM of Vault CDMS, site, and patient solutions, Veeva, stated that the COVID-19 pandemic generated a greater urgency for clinical trials to be more virtual and to bring in safe and an appropriate patient experience.

The sites would have the freedom to utilize the new application with Veeva Vault Clinical and Veeva SiteVault applications along with third-party clinical applications as well. The app would be released and made accessible from December 2020.

Source credit: https://www.businesswire.com/news/home/20200519005365/en/Veeva-Announces-MyVeeva-Enable-Patient-Centric-Clinical-Trials



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Pfizer’s XALKORI®) Approved by US FDA for ALK-positive ALCL treatment
Pfizer’s XALKORI®) Approved by US FDA for ALK-positive ALCL treatment
By Pankaj Singh

The pharma giant Pfizer Inc. has reportedly declared that the U.S. Food and Drug Administration (US FDA) has approved the sNDA (supplemental New Drug Application) for XALKORI® (crizotinib) for the treatment of chil...

JCB unites with ACI Worldwide to boost merchant acquiring capabilities
JCB unites with ACI Worldwide to boost merchant acquiring capabilities
By Pankaj Singh

JCB International, a credit card company, has reportedly partnered with ACI Worldwide, a payment system company, to increase merchant acquiring capabilities across the globe.

The To...

Wide occurrence of aortic stenosis to boost transcatheter aortic valve replacement demand
Wide occurrence of aortic stenosis to boost transcatheter aortic valve replacement demand
By Pankaj Singh

Research and development in the global transcatheter heart valve replacement industry have been gathering pace in recent years, with the increasing occurrence of valvular heart diseases and the demand for less invasive...